HOUT-04. ASSOCIATION OF COMMON PATIENT-REPORTED IMMUNOTHERAPY SYMPTOMATIC SIDE EFFECTS AND PSEUDOPROGRESSION IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS

Yamini Vyas; Elizabeth Vera; Christine Bryla; Sonja Crandon; Jing Wu; Kathleen Wall; Brett Theeler; Christine Siegel; Jennifer Reyes; Marta Penas-Prado; Nicole Leggiero; Christine Cordova; Eric Burton; Ramya Antony; Lisa Boris; Orwa Aboud; Mark Gilbert; Terri Armstrong

doi:10.1093/neuonc/noz175.469

HOUT-04. ASSOCIATION OF COMMON PATIENT-REPORTED IMMUNOTHERAPY SYMPTOMATIC SIDE EFFECTS AND PSEUDOPROGRESSION IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS

Yamini Vyas, Elizabeth Vera, Christine Bryla, Sonja Crandon, Jing Wu, Kathleen Wall, Brett Theeler, Christine Siegel, Jennifer Reyes, Marta Penas-Prado, Nicole Leggiero, Christine Cordova, Eric Burton, Ramya Antony, Lisa Boris, Orwa Aboud, Mark Gilbert, Terri Armstrong

Neurology

Research output: Contribution to journal › Article › peer-review

Abstract

BACKGROUND: Immunotherapy agents have unique symptomatic side effects; patient-reported outcomes (PROs) can help to characterize the benefits and burdens associated with therapy. Common immunotherapyassociated symptoms include pain, fatigue, shortness of breath, and irregular bowel patterns. The purpose of this study was to assess the severity of symptoms and their association with imaging changes in CNS tumor patients undergoing single agent or combination treatment with immune checkpoint inhibitors (ICIs).

Original language	American English
Pages (from-to)	vi112-vi112
Journal	Neuro-Oncology
Volume	21
Issue number	Supplement_6
DOIs	https://doi.org/10.1093/neuonc/noz175.469
State	Published - Nov 2019

Access to Document

10.1093/neuonc/noz175.469

Cite this

Vyas, Y., Vera, E., Bryla, C., Crandon, S., Wu, J., Wall, K., Theeler, B., Siegel, C., Reyes, J., Penas-Prado, M., Leggiero, N., Cordova, C., Burton, E., Antony, R., Boris, L., Aboud, O., Gilbert, M., & Armstrong, T. (2019). HOUT-04. ASSOCIATION OF COMMON PATIENT-REPORTED IMMUNOTHERAPY SYMPTOMATIC SIDE EFFECTS AND PSEUDOPROGRESSION IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS. Neuro-Oncology, 21(Supplement_6), vi112-vi112. https://doi.org/10.1093/neuonc/noz175.469

@article{3fd1c90e07b648569035b3a6b0aa3a11,

title = "HOUT-04. ASSOCIATION OF COMMON PATIENT-REPORTED IMMUNOTHERAPY SYMPTOMATIC SIDE EFFECTS AND PSEUDOPROGRESSION IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS",

abstract = "BACKGROUND: Immunotherapy agents have unique symptomatic side effects; patient-reported outcomes (PROs) can help to characterize the benefits and burdens associated with therapy. Common immunotherapyassociated symptoms include pain, fatigue, shortness of breath, and irregular bowel patterns. The purpose of this study was to assess the severity of symptoms and their association with imaging changes in CNS tumor patients undergoing single agent or combination treatment with immune checkpoint inhibitors (ICIs).",

author = "Yamini Vyas and Elizabeth Vera and Christine Bryla and Sonja Crandon and Jing Wu and Kathleen Wall and Brett Theeler and Christine Siegel and Jennifer Reyes and Marta Penas-Prado and Nicole Leggiero and Christine Cordova and Eric Burton and Ramya Antony and Lisa Boris and Orwa Aboud and Mark Gilbert and Terri Armstrong",

year = "2019",

month = nov,

doi = "10.1093/neuonc/noz175.469",

language = "American English",

volume = "21",

pages = "vi112--vi112",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "Supplement_6",

}

Vyas, Y, Vera, E, Bryla, C, Crandon, S, Wu, J, Wall, K, Theeler, B, Siegel, C, Reyes, J, Penas-Prado, M, Leggiero, N, Cordova, C, Burton, E, Antony, R, Boris, L, Aboud, O, Gilbert, M & Armstrong, T 2019, 'HOUT-04. ASSOCIATION OF COMMON PATIENT-REPORTED IMMUNOTHERAPY SYMPTOMATIC SIDE EFFECTS AND PSEUDOPROGRESSION IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS', Neuro-Oncology, vol. 21, no. Supplement_6, pp. vi112-vi112. https://doi.org/10.1093/neuonc/noz175.469

TY - JOUR

T1 - HOUT-04. ASSOCIATION OF COMMON PATIENT-REPORTED IMMUNOTHERAPY SYMPTOMATIC SIDE EFFECTS AND PSEUDOPROGRESSION IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS

AU - Vyas, Yamini

AU - Vera, Elizabeth

AU - Bryla, Christine

AU - Crandon, Sonja

AU - Wu, Jing

AU - Wall, Kathleen

AU - Theeler, Brett

AU - Siegel, Christine

AU - Reyes, Jennifer

AU - Penas-Prado, Marta

AU - Leggiero, Nicole

AU - Cordova, Christine

AU - Burton, Eric

AU - Antony, Ramya

AU - Boris, Lisa

AU - Aboud, Orwa

AU - Gilbert, Mark

AU - Armstrong, Terri

PY - 2019/11

Y1 - 2019/11

N2 - BACKGROUND: Immunotherapy agents have unique symptomatic side effects; patient-reported outcomes (PROs) can help to characterize the benefits and burdens associated with therapy. Common immunotherapyassociated symptoms include pain, fatigue, shortness of breath, and irregular bowel patterns. The purpose of this study was to assess the severity of symptoms and their association with imaging changes in CNS tumor patients undergoing single agent or combination treatment with immune checkpoint inhibitors (ICIs).

AB - BACKGROUND: Immunotherapy agents have unique symptomatic side effects; patient-reported outcomes (PROs) can help to characterize the benefits and burdens associated with therapy. Common immunotherapyassociated symptoms include pain, fatigue, shortness of breath, and irregular bowel patterns. The purpose of this study was to assess the severity of symptoms and their association with imaging changes in CNS tumor patients undergoing single agent or combination treatment with immune checkpoint inhibitors (ICIs).

UR - https://www.mendeley.com/catalogue/fe7658a3-eb6d-3d63-9825-04b97aa357a9/

U2 - 10.1093/neuonc/noz175.469

DO - 10.1093/neuonc/noz175.469

M3 - Article

SN - 1522-8517

VL - 21

SP - vi112-vi112

JO - Neuro-Oncology

JF - Neuro-Oncology

IS - Supplement_6

ER -